Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Randomized, Controlled, Parallel-Group Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes

NCT04886388 is registered in ClinicalTrials.gov with Better Therapeutics as lead sponsor.

NCT NCT04886388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04886388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Randomized, Controlled, Parallel-Group Trial of a Digital Therapeutic for the Treatment of Type 2 Diabetes
Lead sponsor
Better Therapeutics
Phase
Phase 3
Overall status
Completed
Start date
April 22, 2021
Completion date
September 27, 2022
Enrollment
668 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes